Skip to content
Delayed ~15 min

IPSC CENTURY THERAPEUTICS

Permanent stock page ↗

Health Care · Russell 2000

Next earnings: Thu 12 Nov 2026 · estimated

What 8 analyst firms say about CENTURY THERAPEUTICS: their latest ratings, price targets and how far the stock is from them. How it works

1.68 USD+0.17 (+11.26%) today
Price as of 6 Nov 16:00 ET

Analyst window: Latest analyst report within last 1 year

Analyst view · last 1Y

+204.8%to the avg target 5.12 USD+3.44 USD
Buy 5 · Hold 2 · Sell 0

7 rated views · 8 analyst/firm records · 8 firms

Latest report13 Aug 2026avg report date 1 May
Target rangePrice is below every target

Radar score

  • Russell 2000 · Top Picks · 6MNot scored · Fewer than 4 price targets in the last 6 months (3)
  • Russell 2000 · Safest consensus · 6MNot scored · Fewer than 4 price targets in the last 6 months (3)

Recent analyst activity · last 90 days

Our tracked history has 3 reports on IPSC from 3 analyst firms in the last 90 days (8 firms in the past year).

Comparing each firm's latest target with its previous one: 1 has its first observed target in the past year.

No firm's latest available rating differs from its previous one.

Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.

FirmAnalystLatest ratingReport dateLatest target (USD)
Clear Street LLCKaveri PohlmanBuy13 Aug 20266.60 USD
H.C. WainwrightMitchell S KapoorBuy19 May 20265.00 USD
Leerink PartnersDaina GrayboschHold13 Mar 20262.00 USD
MizuhoSalim SyedBuy27 May 20268.00 USD
Piper SandlerEdward A TenthoffBuy12 Aug 20264.00 USD · 20 Jan 2026
TD CowenPhilip M NadeauBuy25 Feb 2026—
Weiss RatingsUnnamed analyst—29 Sep 2026—
Data feed RESEARCHResearch TeamHold12 Mar 2026—

Partial coverage · checked 6 Nov (6 Nov 2026, 07:07 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.